Chris Jones, CRUK Clinician Scientist and Assistant Research Professor at the University of Cambridge, shared on LinkedIn:
“This is excellent. Really important work for The Royal College of Radiologists to be leading on with British Nuclear Medicine Society.”
The Royal College of Radiologists (RCR), added:
“The National Cancer Plan for England identified molecular radiotherapy (MRT) as a research priority.
Last week, we partnered with the British Nuclear Medicine Society (BNMS) to bring together key partners driving MRT research across the UK for a roundtable discussion.
Together, we explored what needs to happen to ensure more patients can benefit from MRT research, including:
- Stronger national, cross-government coordination on MRT
- A more resilient radionuclide supply chain
- Better use of existing networks to support the delivery of clinical trials across the UK
We look forward to sharing the outcomes of these important discussions in the new year.”

